C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/85 (2006.01) A61K 31/70 (2006.01) A61K 48/00 (2006.01) C07K 14/47 (2006.01) C12N 15/12 (2006.01) C12N 15/63 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2255141
The present application discloses nucleic acid constructs for the gene therapy of diseases, which constructs comprise nucleic acids which encode a protein which inhibits the cellular protein p27 and thereby relieves the inhibition of the proliferation of the cell which is brought about by p27, mutants thereof, some of which possess a dominant interfering character, and the use of these nucleic acids for the prophylaxis and therapy of diseases.
Buergin Andrea
Eilers Martin
Sedlacek Hans-Harald
Aventis Pharma Deutschland Gmbh
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Hoechst Marion Roussel Deutschland Gmbh
LandOfFree
Nucleic acid constructs for gene therapy whose activity is... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleic acid constructs for gene therapy whose activity is..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid constructs for gene therapy whose activity is... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1732833